Related Experiment Video
Updated: May 9, 2025
A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
A Review of Pediatric Influenza
Insights
Pediatric influenza poses significant health risks, with specific genetic and immune factors worsening outcomes. Addressing declining vaccination rates and hesitancy is crucial for protecting children from this widespread respiratory illness.
Area of Science:
- Pediatric Infectious Diseases
- Immunology
- Public Health
Background:
- Influenza is a major global health threat, especially for pediatric populations.
- Severe influenza in children is linked to genetic factors, immune responses, and neutrophil activation.
Purpose of the Study:
- To provide a comprehensive overview of pediatric influenza, covering its pathophysiology, epidemiology, clinical features, treatment, and prevention.
- To inform clinical practice and guide future research in pediatric influenza management.
Main Methods:
- This study is a comprehensive literature review.
- It synthesizes current knowledge on pediatric influenza from various scientific sources.
Main Results:
- Influenza affects 8-10% of US children annually, with disproportionately higher hospitalization rates among minority ethnic groups.
- Children often present with more severe symptoms and gastrointestinal issues compared to adults.
- Neuraminidase inhibitors (e.g., oseltamivir) and baloxavir marboxil are effective treatments.
Conclusions:
- Vaccination is key for pediatric influenza prevention, but declining uptake and vaccine hesitancy are significant challenges.
- Research into universal influenza vaccines is ongoing and promising for enhanced protection.
- Effective management requires understanding risk factors, clinical presentation, and available treatments.
Abstract:
Influenza remains a significant public health concern, particularly among children. This comprehensive review focuses on pathophysiology, epidemiology, clinical presentation, treatment, and vaccines for pediatric influenza. Key genetic and immune-related factors, as well as excessive neutrophil activation, contribute to severe disease and outcomes. Epidemiologically, influenza affects 8% to 10% of children in the United States annually, with higher hospitalization rates among children who are Black, Hispanic, Native American and Alaska Native, and Asian and Pacific Islander. Clinically, children exhibit more severe symptoms and higher rates of gastrointestinal manifestations compared with adults. Treatment primarily involves neuraminidase inhibitors, like oseltamivir; although, therapies, such as baloxavir marboxil, are also effective. Vaccination remains the cornerstone of prevention, yet declining rates of uptake and increasing vaccine hesitancy pose challenges for population immunity. Universal influenza vaccine research offers hope for broader protection. This review aims to inform evidence-based practices in managing pediatric influenza and highlights areas for future research. [.
Related Concept Videos
01:51Vaccinations
00:57Viral Recombination
00:36Viral Mutations
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:30Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause: